(A) Cmpds. (I) and (III):- R' = lower alkyl R2 = H or Me R3 = lower Oalkyl or together = -OCH2O-IA - X = H; IB X = double bond. (B) Sa
(A) Cmpds. (I) and (III):- R' = lower alkyl R2 = H or Me R3 = lower Oalkyl or together = -OCH2O-IA - X = H; IB - X = double bond. (B) Salts (II) of (I). (I) and (II) Analgesics. Dose 100-500 mg. (III) Intermediates for (I) and (II) Racemic cis-1-methyl-3-(3,4-methylenedioxy-phenyl)-4-piperidyl-...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | (A) Cmpds. (I) and (III):- R' = lower alkyl R2 = H or Me R3 = lower Oalkyl or together = -OCH2O-IA - X = H; IB - X = double bond. (B) Salts (II) of (I). (I) and (II) Analgesics. Dose 100-500 mg. (III) Intermediates for (I) and (II) Racemic cis-1-methyl-3-(3,4-methylenedioxy-phenyl)-4-piperidyl-amine (6.0 g.), 2 N HCl (35 ml.), and 35% HCHO (5 g.) were stirred 30 mins. at 20 deg., heated 30 mins. at 100 deg., evapd., and recryst. from MeOH, giving the racemic-naphthyridine-HCl, m.p. 304 deg. |
---|